학술논문
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
Document Type
Report
Author
Source
Journal of Psychopharmacology. May, 2016, Vol. 30 Issue 5, p428, 8 p.
Subject
Language
English
ISSN
0269-8811